Ryan Martins - 04 Apr 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Financial Officer
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Issuer symbol: ETNB
Transactions as of: 04 Apr 2023
Net transactions value: -$130,379
Form type: 4
Filing time: 06 Apr 2023, 16:06:27 UTC
Previous filing: 04 Apr 2023
Next filing: 05 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Sale	$130,379	-8,721	-14%	$14.95	53,578	04 Apr 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022 in multiple trades at prices ranging from $14.81 to $15.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Content

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 16, 2022 in multiple trades at prices ranging from $14.81 to $15.16. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.